The immunology of pulmonary fibrosis: The role of TH1/TH2/TH17/Treg cells

Pneumon

Volumn 23, Issue 1, 2010, Pages 13-20

  Tzouvelekis, Argyris ^a   Bouros, Evangelos ^a   Bouros, Demosthenes ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; INTERLEUKIN 13; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 2; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSFORMING GROWTH FACTOR;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EDITORIAL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; IMMUNOREGULATION; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; NONHUMAN; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 77953386598     PISSN: 1105848X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (18)

1. Gross TJ, Hunninghake GW Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517-525.
2. Strieter RM Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel.Chest 2005;128:526S-532S.
3. Agostini C, Gurrieri C. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006;3:357-363.
4. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007;13:139-145.
5. Joshi AD, Fong DJ, Oak SR, et al. Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis. Am J Respir Crit Care Med 2009;179:705-716.
6. Simonian PL, Roark CL, Wehrmann F, et al. Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis. J Immunol 2009;182:657-665.
7. Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF. Chatenoud L TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoim-mune diabetes. Nat Med 2003;9:1202-1208.
8. Bettelli E, Carrier Y, Gaoet W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-238.
9. Huang MC, Liao JJ, Bonasera S, Longo DL, Goetzl EJ. Nuclear factor-kappaB-dependent reversal of aging-induced alterations in T cell cytokines. FASEB J 2008;22:2142-2150.
10. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004;10:801-805.
11. Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 2009;179:772-781.
12. Feghali-Bostwick CA, Tsai CG, Valentine VG, et al. Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol 2007;179:2592-2599.
13. Miyara M, Amoura Z, Parizot C, et al, Chapelon-Abric, P. Debre, J. C. Piette, and G. Gorochov. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006;203:359-370.
14. Grunewald J, Eklund A. Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 2007;4:461-464.
15. Kotsianidis I, Nakou E, Bouchliou I, et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonaryfibrosis. Am J Respir Crit Care Med 2009;179:1121-1130.
16. D'Alessio FR, Tsushima K, Aggarwal NR, et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 2009;119:2898-2913.
17. Mark AAC, de Knegt RJ, Tilanus HW et al. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J Hepatol 2010;52:315-321
18. Bouros D. Sexy and 17: Two novel pathways in immune regulation. Pneumon 2009;19:216-218